F. Gallucci

Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer.

W. Nahas, M. Srougi, R. Coelho, 2017, Revista da Associacao Medica Brasileira.

Prospective evaluation of a urinary biomarker panel to detect and predict recurrence of non-muscle-invasive bladder cancer

W. Nahas, M. Srougi, S. Reis, 2020, World Journal of Urology.

Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer.

W. Nahas, M. Srougi, R. Coelho, 2017, Revista da Associacao Medica Brasileira.

Predicting individual outcomes after radical cystectomy in urothelial variants with Cancer of the Bladder Risk Assessment (COBRA) score

W. Nahas, L. Ribeiro-Filho, M. Cordeiro, 2024, World journal of urology.

Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.

V. Gaborieau, K. Nepple, Vidit Sharma, 2024, Nature genetics.